Controlled Substances Regulations (SOR/2025-242)
Full Document:
- HTMLFull Document: Controlled Substances Regulations (Accessibility Buttons available) |
- XMLFull Document: Controlled Substances Regulations [670 KB] |
- PDFFull Document: Controlled Substances Regulations [1157 KB]
Regulations are current to 2026-10-29 and last amended on 2026-10-01. Previous Versions
Marginal note:Sale to individual
98 (1) A pharmacist may sell or provide a controlled substance to an individual if
(a) the sale or provision is for the individual’s own use, for the use of another individual or for an animal;
(b) the controlled substance is in the form of a finished product that does not contain a restricted drug; and
(c) subject to subsection (2), the pharmacist first receives the following in respect of the controlled substance from one of the following persons:
(i) in the case of the individual, a written prescription,
(ii) in the case of another pharmacist or a pharmacy technician,
(A) a written prescription, or
(B) a copy of the document on which the information with respect to a verbal prescription has been recorded under section 117, or
(iii) in the case of a practitioner, a written or verbal prescription.
Marginal note:Finished product containing low dose of codeine
(2) A pharmacist may sell or provide, without a prescription, a finished product containing codeine phosphate to an individual if
(a) the finished product contains
(i) in the case of a finished product in solid form, not more than 8 mg or its equivalent of codeine phosphate per unit, or
(ii) in the case of a finished product in liquid form, not more than 20 mg or its equivalent of codeine phosphate per 30 mL;
(b) the finished product contains
(i) two additional medicinal ingredients other than a narcotic in a quantity of not less than the regular minimum single dose for one such ingredient or one-half of the regular minimum single dose for each such ingredient, or
(ii) three additional medicinal ingredients other than a narcotic in a quantity of not less than the regular minimum single dose for one such ingredient or one-third of the regular minimum single dose for each such ingredient;
(c) the pharmacist has reasonable grounds to believe that the finished product will only be used for recognized medical purposes; and
(d) the pharmacist ensures that the following caution or its equivalent is conspicuously and legibly printed on the finished product’s inner label and outer label, as those terms are defined in section A.01.010 of the Food and Drug Regulations:
“This product contains codeine and should not be administered to children except on the advice of a physician, dentist or nurse practitioner.”
Page Details
- Date modified: